THE Philippines is free to produce a generic version of Tamiflu, a known antibird flu drug, at its discretion and without paying compensation to Swiss-based Roche pharmaceuticals. In a Nov. 23 letter to Senator Mar Roxas, Roche Philippines general manager Warwick Bedwell said that Tamiflu, otherwise known as “oseltamivir,” is not patent-protected in the Philippines, “therefore, voluntary or compulsory licensing cannot be pursued where no patent protection exists.”
Read the Manila Standard Today for the full story.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment